Article

Charcoal haemoperfusion in amitriptyline poisoning: experience in 20 children.

Ondokuz Mayis University Faculty of Medicine, Department of Pediatric Nephrology, Samsun, Turkey.
Nephrology (impact factor: 1.31). 07/2008; 13(3):193-7. DOI:10.1111/j.1440-1797.2008.00922.x pp.193-7
Source: PubMed

ABSTRACT Tricyclic antidepressant (TCA) toxicity is common among children and adults due to widespread use. Amitriptyline (AT) is one of the most commonly prescribed TCAs. Current guidelines do not recommend charcoal haemoperfusion (HP) for AT overdose due to high protein binding and large volume of distribution. However evidence regarding the efficacy of charcoal HP in addition to supportive measures is accumulating in the published reports.
Here we report our experience in 20 children (15 girls, 5 boys) with acute AT overdose aged between 1.5 and 15 years, successfully managed with HP in our institution between January 2000 and February 2007.
The HP indications were mainly severe initial cardiac and respiratory involvement. After HP, all patients recovered dramatically with a mean hospital stay of 4 days (range: 2-12). Only one patient developed neurological sequelae due to prolonged hypoxia secondary to respiratory arrest.
To our knowledge this is the largest case series reporting the efficacy of charcoal HP in acute AT overdose in children. Based on our findings, charcoal HP seems to be an effective treatment modality, especially in prompt correction of severe life-threatening cardiac and respiratory findings in children with serious AT overdose and resulting in a reduction of morbidity and mortality.

0 0
 · 
0 Bookmarks
 · 
19 Views

Keywords

20 children
 
4 days
 
Amitriptyline
 
charcoal haemoperfusion
 
charcoal HP
 
correction
 
Current guidelines
 
effective treatment modality
 
HP indications
 
large volume
 
largest case series
 
mean hospital
 
neurological sequelae
 
protein binding
 
published reports
 
respiratory arrest
 
respiratory findings
 
severe life-threatening cardiac
 
TCAs
 
Tricyclic antidepressant
 

Kenan Bek